How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

4,076 results for

Physical Medicine

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Guidelines for the Safe Management and Use of Medications in Anaesthesia

have a significant impact on availability of essential medications when there are interruptions to supply. 5.1.2 If feasible, a designated pharmacist should liaise with a designated (clinical) drug safety officer in the department of anaesthesia or pain medicine over all decisions on relevant drug purchasing and presentation. In the absence of an anaesthesia department an anaesthetist should be nominated/designated to undertake such liaison. 5.1.3 The labelling and packaging of drugs should (...) of controlled medicines should be according to jurisdictional requirements. 5.9 INTRAVENOUS INFUSION OF MEDICATIONS 5.9.1 Wherever practicable infusion pumps and syringe drivers used for the administration of intravenous drugs should be standardised within an institution. Page 7 PS51 2018 5.9.2 When drugs are given by infusion, the patient end of the infusion line should be labelled and precautions taken with one-way valves to avoid any siphoning of the infused drug. Valve design should

2017 Australian and New Zealand College of Anaesthetists

22. Guidelines on Sedation and/or Analgesia for Diagnostic and Interventional Medical, Dental or Surgical Procedures Background Paper

Administering Local Anaesthesia and PS03 Guidelines for the Management of Major Regional Analgesia). BACKGROUND This section is intended to provide background information for the key quality and safety concepts in this professional document. Page 2 PS09 BP 2014 Personnel for sedation and/or analgesia Sedative drugs are administered to facilitate diagnostic and interventional procedures by medical practitioners from many specialties, including anaesthesia, pain medicine, surgery, emergency medicine (...) , intensive care medicine, radiology, gastroenterology and other sub- specialties of internal medicine. Dentists also engage in the practice of procedural sedation and/or analgesia. While anaesthetists are the acknowledged experts in procedural sedation and/or analgesia, it is impossible and unnecessary for anaesthetists to administer all procedural sedation and/or analgesia in Australia and New Zealand. For this reason, PS09 is designed to promote high standards of training and practice for all medical

2014 Australian and New Zealand College of Anaesthetists

23. Guidelines on Sedation and/or Analgesia for Diagnostic and Interventional Medical, Dental or Surgical Procedures

procedural sedation and/or analgesia requires sufficient training to be able to: 5.3.1 Understand the actions of the drugs being administered, and be able to modify the technique appropriately in patients of different ages, or in the case of concurrent drug therapy or disease processes. 5.3.2 Monitor the patient’s level of consciousness and cardiorespiratory status. 5.3.3 Detect and appropriately manage any complications arising from sedation. 5.4 A medical or dental practitioner who is skilled in airway (...) Guidelines on Sedation and/or Analgesia for Diagnostic and Interventional Medical, Dental or Surgical Procedures PS09 2014 Page 1 PS09 2014 Australian and New Zealand College of Anaesthetists (ANZCA) Faculty of Pain Medicine The following organisations have endorsed this document: Australasian College for Emergency Medicine College of Intensive Care Medicine of Australia and New Zealand Gastroenterological Society of Australia New Zealand Society for Gastroenterology Royal Australasian College

2014 Australian and New Zealand College of Anaesthetists

24. Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications

Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications Interventional Spine and Pain Procedures in Patients on Anti... : Regional Anesthesia and Pain Medicine You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page. Login No user account? Lippincott Journals Subscribers , use your username or email along with your password to log in. Remember me on this computer Register for a free account (...) and the evidentiary basis for such recommendations. This publication is intended as a living document to be updated periodically with consideration of new evidence. From the *Western Reserve Hospital, Cuyahoga Falls, OH; †Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago, IL; ‡Pain Diagnostics and Interventional Care, Pittsburgh, PA; §Department of Anesthesiology, Rush University Medical Center, Chicago, IL; ∥Valencia University Medical School and Department

2018 American Society of Regional Anesthesia and Pain Medicine

25. Routine psychosocial care in infertility and medically assisted reproduction ? A guide for fertility staff

Routine psychosocial care in infertility and medically assisted reproduction ? A guide for fertility staff ESHRE Psychology and Counselling Guideline Development Group March 2015 Routine psychosocial care in infertility and medically assisted reproduction – A guide for fertility staff 1 Disclaimer The European Society of Human Reproduction and Embryology (hereinafter referred to as 'ESHRE') developed the current clinical practice guideline to provide clinical recommendations to improve (...) every effort to compile accurate information and to keep it up-to-date, it cannot, however, guarantee the correctness, completeness, and accuracy of the guideline in every respect. In any event, these clinical practice guidelines do not necessarily represent the views of all clinicians that are members of ESHRE. The information provided in this document does not constitute business, medical, or other professional advice, and is subject to change. 2 CONTENTS Disclaimer 2 I. Introduction and scope

2015 European Society of Human Reproduction and Embryology

26. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas

for bilateral A VS to distinguish APA from PAH and referred to a medical center familiar with this procedure. Patients too infirm for surgical management, those with a limited life expectancy, and those comfortable with medical therapy utilizing mineralocorticoid receptor blockers need no further evaluation (65 [EL 4], 71 [EL 2], 72 [EL 2], 75 [EL 4], 76 [EL 4]). Patients should discon- tinue the use of spironolactone for 6 weeks and eplerenone for 4 weeks before A VS. The success of A VS is very much (...) American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas ENDOCRINE PRACTICE Vol 15 (Suppl 1) July/August 2009 1 AACE/AAES Guidelines © 2009 AACE. AmERICAN ASSOCIATION Of ClINICAl ENDOCRINOlOgISTS AND AmERICAN ASSOCIATION Of ENDOCRINE SuRgEONS mEDICAl guIDElINES fOR ThE mANAgEmENT Of ADRENAl INCIDENTAlOmAS Martha A. Zeiger, MD, FACS, FACE; Geoffrey B. Thompson, MD, FACS, FACE; Quan-Yang Duh

2009 American Association of Clinical Endocrinologists

27. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Growth Hormone Use in Growth Hormone-deficient Adults and Transition Patients

= Food and Drug Administration; GH = growth hormone; GHD = growth hormone defi- ciency; GHRH = growth hormone releasing hormone; IGF = insulin-like growth factor; IGFBP = insulin-like growth factor binding protein; ITT = insulin tolerance test; QOL = quality of life; SDS = social desirability score 1. MISSION STATEMENT For adults, proven benefits of recombinant human growth hormone (GH) replacement therapy have been demonstrated in those with GH deficiency (GHD) (1 [EL 2], 2 [EL 2], 3 [EL 1], 4 [EL 2 (...) GH from 1985 onward has given rise to many studies investigating the role of GH in adulthood, in particular the effects and safety of GH replacement in GH-deficient adults (10 [EL 2], 11 [EL 3]). In the United States, recombinant GH was approved by the Food and Drug Administration (FDA) in 1996 for use as replacement therapy in GH-deficient adults. Although treatment appears to be safe overall in the first decade of use in adults, certain parameters still necessitate long-term surveillance

2009 American Association of Clinical Endocrinologists

28. British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum

Care if involved. The care plan should be dis- tributed widely among all involved health profession- als. Such care plans should take into account and describe: | | The woman’s obstetric, physical and mental health care needs. | | Ongoing medication and psychosocial interventions and steps to address relapse prevention. | | Information about any relevant monitoring issues (e.g. of lithium levels), medication dose adjustments, interactions with other drugs that could be pre- scribed in the pregnancy (...) of Pharmaceutical Science, King’s College London, London, UK 25 Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK 26 University of Manchester, Manchester, UK 27 UK Teratology Information Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK 28 Institute of Genetic Medicine, Newcastle University, Newcastle, UK Corresponding author: R H McAllister-Williams, Academic Psychiatry, Wolfson Research Centre, Campus for Ageing and Vitality, Newcastle upon Tyne, NE4 5PL

2017 British Association for Psychopharmacology

29. Guidelines on Sedation and/or Analgesia for Diagnostic and Interventional Medical, Dental or Surgical Procedures

procedural sedation and/or analgesia requires sufficient training to be able to: 5.3.1 Understand the actions of the drugs being administered, and be able to modify the technique appropriately in patients of different ages, or in the case of concurrent drug therapy or disease processes. 5.3.2 Monitor the patient’s level of consciousness and cardiorespiratory status. 5.3.3 Detect and appropriately manage any complications arising from sedation. 5.4 A medical or dental practitioner who is skilled in airway (...) Guidelines on Sedation and/or Analgesia for Diagnostic and Interventional Medical, Dental or Surgical Procedures PS09 2014 Page 1 PS09 2014 Australian and New Zealand College of Anaesthetists (ANZCA) Faculty of Pain Medicine The following organisations have endorsed this document: Gastroenterological Society of Australia Royal Australasian College of Surgeons Australasian College for Emergency Medicine College of Intensive Care Medicine of Australia and New Zealand Royal Australian and New

2014 Australian and New Zealand College of Anaesthetists

30. Evolution of Critical Care Cardiology: Transformation of the Cardiovascular Intensive Care Unit and the Emerging Need for New Medical Staffing and Training Models Full Text available with Trip Pro

of critical care is advancing substantially in its complexity. Moreover, accumulating evidence has indicated that outcomes are better when critical care is provided by specially trained providers in a dedicated intensive care unit (ICU). In the context of this evolution, provision of optimal care in the contemporary cardiac ICU (CICU) presents a different set of challenges and requires an expanded set of skills compared with 10 years ago. Cardiovascular medicine has lagged behind other medical disciplines (...) and improved therapeutics have altered the natural history of critical illness in some groups of patients previously considered unsalvageable, thereby increasing the length of stay, risk of iatrogenic complications, and resource consumption. As a result of each of these trends, the medical and procedural issues that determine outcome in the contemporary CCU are often ones that require substantial expertise in general critical care medicine. For example, CCUs now appear strikingly similar to general medical

2012 American Heart Association

31. Medical Director Responsibilities for Outpatient Cardiac Rehabilitation/Secondary Prevention Programs: 2012 Update Full Text available with Trip Pro

, West Haverstraw, New York, and Columbia University, New York, New York (M.K.); Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham (V.B.); Harrington Heart and Vascular Institute, University Hospitals Case Medical Center, and Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio (R.J.); Governmental Representation with Quality, LLC, Vienna, Virginia (K.L.); Cardiovascular Health Clinic, Division of Cardiovascular (...) Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota (R.J.T.); and Division of Cardiology, Creighton University School of Medicine, Omaha, Nebraska (M.A.W.). Marjorie King From Helen Hayes Hospital, West Haverstraw, New York, and Columbia University, New York, New York (M.K.); Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham (V.B.); Harrington Heart and Vascular Institute, University Hospitals Case Medical Center, and Department

2012 American Heart Association

32. AACE Medical Guidelines for Clinical Practice for Diagnosis and Treatment of Menopause

, pheochromocytoma, carcinoid, panic disorder, diabetes, and side effects to medications such as antiestrogens or selective estrogen receptor modulators. Numerous RCTs have proved the efficacy of estro - gen in treating menopausal symptoms (15 [EL 1; RCT], 16 [EL 4; NE]). In addition, estrogen therapy may im- prove mood disorders (depression), cognitive disruption, and sexual dysfunction during early menopause (15 [EL 1; RCT], 16 [EL 4; NE]). It should be emphasized that not all mood disorders or cognitive (...) . In fact, compounded prepara- tions for the treatment of menopause may contain estradiol, estrone, estriol, progesterone, testosterone, and dehydro- epiandrosterone, which are not found naturally in plants but are synthesized from botanical precursor sterols. These preparations are compounded by pharmacists—as pills, gels, creams, suppositories, or injectable solutions (31 [EL 4; NE], 32 [EL 4; NE]). In contrast to commercially pro- duced pharmaceutical agents, compounded medications are not subjected

2011 American Association of Clinical Endocrinologists

33. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly

University, Portland, Oregon Shereen Z. Ezzat, MD, FRCPC Department of Medicine and Endocrinology, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada Amir H. Hamrahian, MD, F ACE Department of Endocrinology, Diabetes and Metabolism, Cleveland Clinic, Cleveland, Ohio Karen K. Miller, MD Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts Reviewers William H. Ludlam, MD, PhD Susan L. Samson, MD, PhD, F ACE Steven (...) - crine neoplasia type 1; MRI = magnetic resonance imaging; OGTT = oral glucose tolerance test; R = rec- ommendation; RT = radiation therapy; SSAs = soma- tostatin analogues 1. INTRODUCTION Acromegaly is a disorder characterized by growth hor- mone (GH) hypersecretion, multisystem-associated mor- bidities, and increased mortality. In 2004, the American Association of Clinical Endocrinologists (AACE) pub- lished medical guidelines for the clinical management of acromegaly (1 [“evidence level” or EL 4

2011 American Association of Clinical Endocrinologists

34. Beyond Medications and Diet: Alternative Approaches to Lowering Blood Pressure Full Text available with Trip Pro

to avoid or delay drug therapy when clinically appropriate. Fourth, there is an increasing prevalence of resistant hypertension. Combination strategies incorporating these alternative approaches might be helpful to achieve BP control among individuals with resistant hypertension. Fifth, most of the reviewed alternative approaches pose little to no side effects and could thus represent acceptable options for individuals with multiple medication intolerances. Finally, despite numerous efforts (...) that included alternative BP-lowering approaches and excluded orally active agents such as dietary changes, complementary therapies, herbs, and novel medications. The writing group then classified the approaches into 3 broad categories: behavioral therapies, including meditation techniques, yoga, biofeedback, and relaxation or stress-reduction programs; noninvasive procedures or devices, including device-guided breathing modulation and acupuncture; and exercise-based regimens, including aerobic, resistance

2013 American Heart Association

35. Safe Medication Use in the ICU Full Text available with Trip Pro

), Agency for Healthcare Research and Quality (AHRQ), Centers for Medicare & Medicaid Services (CMS), and the National Library of Medicine improve consumer-oriented drug information resources and medication self-management support ( ). Overall, several government, as well as, nonprofit organizations have identified medication safety as a priority for healthcare in the United States ( ). The Institute of Healthcare Improvement and Institute for Safe Medication Practices (ISMP) provide tools and resources (...) Safe Medication Use in the ICU Clinical Practice Guideline: Safe Medication Use in the ICU : Critical Care Medicine You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page. Login No user account? Lippincott Journals Subscribers , use your username or email along with your password to log in. Remember me on this computer Register for a free account Registered users can save articles, searches, and manage email alerts. All

2017 Society of Critical Care Medicine

36. AACE/ACE/AME Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules

Professor of Medicine, Mayo Clinic College of Medicine, Past President, American Association of Clinical Endocrinologists, Past President, American Thyroid Association; 2 Director, Department of Endocrinology and Metabolism, Regina Apostolorum Hospital, Via San Francesco 50, 00041, Albano, Rome (Italy); 3 Endocrine Division, Harvard Vanguard Medical Associates, Boston, Massachusetts, Division of Endocrinology , Beth Israel Deaconess Medical Center, Boston, Massachusetts; 4 Endocrinology Associates, PA (...) ” method. Each topic covered by the guidelines was translated to a related question. Accordingly, the bibliographic research was con- ducted by selecting studies able to yield a methodologi- cally reliable answer to each question. The first step was to select pertinent published reports. The U.S. National Library of Medicine Medical Subject Headings (MeSH) database was used as a terminologic filter. Appropriate MeSH terms were identified, and care was taken to select them on a sensitive rather than

2016 American Association of Clinical Endocrinologists

37. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for Comprehensive Medical Care of Patients with Obesity

. The presented recommendations may not be appropriate in all situations. Any decision by practitioners to apply these guidelines must be made in light of local resources and individual patient circumstances. From 1 Professor and Chair, Department of Nutrition Sciences, University of Alabama at Birmingham, Director, UAB Diabetes Research Center, GRECC Investigator & Staff Physician, Birmingham VA Medical Center, Birmingham, Alabama; 2 Director, Metabolic Support, Clinical Professor of Medicine, Division (...) School of Medicine, Internal Medicine, Endocrinology, Pediatrics, Pediatric Endocrinology, New Haven, Connecticut; 7 Walter Reed National Military Medical Center, Diabetes Obesity & Metabolic Institute, Bethesda, Maryland; 8 Assistant Clinical Professor, Mount Sinai School of Medicine, NY, ProHealth Care Associates, Division of Endocrinology, Lake Success, New York; 9 Center for Weight Management, Division of Endocrinology, Diabetes and Metabolism, Scripps Clinic, San Diego, California. Address

2016 American Association of Clinical Endocrinologists

38. Medical abortion reporting of efficacy: the MARE guidelines

,weconsiderearlymedicalabortionto refer toproceduresinthe first trimester. Reportsofusingmedicalagentstocauseearlyabortionfirst appeared in the 1950s [5], but the modern era of medical abortionresearchstartedintheearly1980swiththediscovery oftestagentsthatwereultimatelydevelopedintomifepristone. Over the past 30 years, research has evolved, with the use of variousdrugsincludingmifepristone,methotrexate,tamoxifen, letrozole and various prostaglandin analogs to induce early abortion [6]. The first drug with a labeled indication (...) Medical abortion reporting of efficacy: the MARE guidelines Commentary Medical abortion reporting of efficacy: the MARE guidelines ?,?? Mitchell D. Creinin ? , Melissa J. Chen Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, CA, USA Received 20 April 2016; accepted 22 April 2016 1. Introduction ThiscommentaryintroducestheMedicalAbortionReporting ofEfficacy(MARE)guidelinesasasupplementtoCONSORT [1] and STROBE [2]. The goal of the recommendations

2016 Society of Family Planning

39. Medical management of first-trimester abortion

of gestations of more than 49 days [24]; this risk will vary based on the regimen used. Pain management is an important consideration. The woman should be sent home with appropriate instructions for analgesia with over-the-counter medications and can be provided with prescriptions for oral narcotics to use when needed. Nonsteroidal antiinflammatory drugs, such as ibuprofen, are not contraindicated in women who undergo a medical abortion and are appropriate first-line agents for pain management. One (...) randomized trial found that ibuprofen taken when needed was more effective than acetaminophen to reduce pain associated with medical abortion [48]. Nonsteroidal antiinflammatory drugs inhibit the synthesis of new prostaglandins, but they do not block the action of prostaglandin receptors and should not inhibit the action of a prostaglandin used for medical abortion. In a retrospective analysis of nonsteroidal antiinflammatory drugs and complete abortion, in 416 women who received misoprostol after

2014 Society of Family Planning

40. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics

of aspirin, nonsteroidal anti- inflammatory drugs, and other medications that reduce or affect platelet function should be avoided. Hypoglycemia risks should be checked before starting medications. Due consideration should be given to medications that have a high sodium or potassium content; the latter is especially important in the setting of renal failure. All patients should be encouraged to participate in age- appropriate physical activities. However, contact or competitive sports should be avoided (...) storage disease type I (GSD I) after reviewing the autopsy reports of two children whose livers and kidneys contained excessive amounts of Submitted 12 August 2014; accepted 12 August 2014; advance online publication 6 November 2014. doi:10.1038/gim.2014.128 Genet Med 00 00 2014 Genetics in Medicine 10.1038/gim.2014.128 ACMG Standards and Guidelines 00 00 12August2014 12August2014 © American College of Medical Genetics and Genomics 6November2014 Purpose: Glycogen storage disease type I (GSD I

2014 American College of Medical Genetics and Genomics

Guidelines

Guidelines – filter by country